相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Swimming exercise stimulates IGF1/ PI3K/Akt and AMPK/SIRT1/PGC1α survival signaling to suppress apoptosis and inflammation in aging hippocampus
Jing-Ying Lin et al.
AGING-US (2020)
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes
Darnel Prakoso et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Guidelines for animal exercise and training protocols for cardiovascular studies
David C. Poole et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Clusterin is regulated by IGF1-PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity
Sebastian Bass-Stringer et al.
ARCHIVES OF TOXICOLOGY (2020)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Class II PI3K Functions in Cell Biology and Disease
Federico Gulluni et al.
TRENDS IN CELL BIOLOGY (2019)
VPS34 complexes from a structural perspective
Yohei Ohashi et al.
JOURNAL OF LIPID RESEARCH (2019)
The Role of the IGF-1 Signaling Cascade in Muscle Protein Synthesis and Anabolic Resistance in Aging Skeletal Muscle
Richie D. Barclay et al.
FRONTIERS IN NUTRITION (2019)
Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies
Yow Keat Tham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling
Bianca C. Bernardo et al.
CLINICAL SCIENCE (2018)
Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure
Sebastian Bass-Stringer et al.
HEART LUNG AND CIRCULATION (2018)
UNDERSTANDING KEY MECHANISMS OF EXERCISE-INDUCED CARDIAC PROTECTION TO MITIGATE DISEASE: CURRENT KNOWLEDGE AND EMERGING CONCEPTS
Bianca C. Bernardo et al.
PHYSIOLOGICAL REVIEWS (2018)
High-fat diet suppresses the positive effect of creatine supplementation on skeletal muscle function by reducing protein expression of IGF-PI3K-AKT-mTOR pathway
Renato Ferretti et al.
PLOS ONE (2018)
Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets
Yow Keat Tham et al.
CELL REPORTS (2018)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction
Darnel Prakoso et al.
CLINICAL SCIENCE (2017)
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
Barry Greenberg et al.
LANCET (2016)
Global Burden of Disease Study 2015 provides GPS for global health 2030
K. Srinath Reddy
LANCET (2016)
ARE THERE DELETERIOUS CARDIAC EFFECTS OF ACUTE AND CHRONIC ENDURANCE EXERCISE?
Thijs M. H. Eijsvogels et al.
PHYSIOLOGICAL REVIEWS (2016)
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
Klaus Okkenhaug et al.
CANCER DISCOVERY (2016)
Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
Bianca C. Bernardo et al.
SCIENTIFIC REPORTS (2016)
Exercise Training in Patients with Heart Disease: Review of Beneficial Effects and Clinical Recommendations
Stephan Gielen et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2015)
Phosphoinositide 3-kinase: friend and foe in cardiovascular disease
Alessandra Ghigo et al.
FRONTIERS IN PHARMACOLOGY (2015)
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
Sahitya K. Denduluri et al.
GENES & DISEASES (2015)
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
Julie R. McMullen et al.
BLOOD (2014)
Signaling pathways controlling skeletal muscle mass
Marc A. Egerman et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy
Bianca C. Bernardo et al.
FASEB JOURNAL (2014)
Classes of phosphoinositide 3-kinases at a glance
Steve Jean et al.
JOURNAL OF CELL SCIENCE (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hypoactivity Affects IGF-1 Level and PI3K/AKT Signaling Pathway in Cerebral Structures Implied in Motor Control
Julien Mysoet et al.
PLOS ONE (2014)
New insights into IGF-1 signaling in the heart
Rodrigo Troncoso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Geeta Sapra et al.
NATURE COMMUNICATIONS (2014)
Molecular basis of physiological heart growth: fundamental concepts and new players
Marjorie Maillet et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Seeing the Light
Adam P. Wojno et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Phosphoinositide 3-Kinase p110α Is a Master Regulator of Exercise-Induced Cardioprotection and PI3K Gene Therapy Rescues Cardiac Dysfunction
Kate L. Weeks et al.
CIRCULATION-HEART FAILURE (2012)
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes
R. H. Ritchie et al.
DIABETOLOGIA (2012)
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
Bianca C. Bernardo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure
Mariell Jessup et al.
CIRCULATION (2011)
Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution
K-M R. Prasad et al.
GENE THERAPY (2011)
Transendocardial Delivery of AAV6 Results in Highly Efficient and Global Cardiac Gene Transfer in Rhesus Macaques
Guangping Gao et al.
HUMAN GENE THERAPY (2011)
Large-scale recombinant adeno-associated virus production
Robert M. Kotin
HUMAN MOLECULAR GENETICS (2011)
PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart Failure Identification of PI3K-Regulated miRNA and mRNA
Ruby C. Y. Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Comparative Cardiac Gene Delivery of Adeno-Associated Virus Serotypes 1-9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart
Carmela Zincarelli et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
The clusterin paradigm in prostate and breast carcinogenesis
Federica Rizzi et al.
ENDOCRINE-RELATED CANCER (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
Lynette Pretorius et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
Brian E. Jaski et al.
JOURNAL OF CARDIAC FAILURE (2009)
Critical assessment of current adeno-associated viral vector production and quantification methods
Marc G. Aucoin et al.
BIOTECHNOLOGY ADVANCES (2008)
Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat
Lawrence T. Bish et al.
HUMAN GENE THERAPY (2008)
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Jaetaek Kim et al.
MOLECULAR ENDOCRINOLOGY (2008)
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo
J. Palomeque et al.
GENE THERAPY (2007)
Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients - A randomized study
Ulrik Wisloff et al.
CIRCULATION (2007)
Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy
Julie R. McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway:: An unexpected effect on TRAIL-induced apoptosis
L Dubská et al.
FEBS LETTERS (2005)
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Z Wang et al.
NATURE BIOTECHNOLOGY (2005)
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway
JR McMullen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Left ventricular morphology and function in female athletes: A meta-analysis
GP Whyte et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2004)
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
JR McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) trial
P Giannuzzi et al.
CIRCULATION (2003)
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes
GGN Serneri et al.
CIRCULATION RESEARCH (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
T Shioi et al.
EMBO JOURNAL (2000)
The athlete's heart - A meta-analysis of cardiac structure and function
BM Pluim et al.
CIRCULATION (2000)
分享论文
